ES2195058T3 - Uso terapeutico de compuestos de dioxabiciclo(3.3.0.)octano. - Google Patents

Uso terapeutico de compuestos de dioxabiciclo(3.3.0.)octano.

Info

Publication number
ES2195058T3
ES2195058T3 ES97112930T ES97112930T ES2195058T3 ES 2195058 T3 ES2195058 T3 ES 2195058T3 ES 97112930 T ES97112930 T ES 97112930T ES 97112930 T ES97112930 T ES 97112930T ES 2195058 T3 ES2195058 T3 ES 2195058T3
Authority
ES
Spain
Prior art keywords
sup
octane
dioxabicyclo
methoxy
methylenedioxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97112930T
Other languages
English (en)
Inventor
Yoshifumi Shinmen
Kengo Akimoto
Sumio Asami
Yoshihide Suwa
Yoshinori Kitagawa
Michihiro Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1187497A external-priority patent/JP3001589B2/ja
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2195058T3 publication Critical patent/ES2195058T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60—Salad dressings; Mayonnaise; Ketchup
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Fats And Perfumes (AREA)

Abstract

USO DE COMPUESTOS DE TIPO DIOXABICICLO[3.3.0]OCTANO REPRESENTADOS POR LA FORMULA GENERAL (I): EN DONDE LOS GRUPOS R SUP,1}, R SUP,2}, R SUP,3}, R SUP,4}, R SUP,5} Y R SUP,6} SE SELECCIONAN INDEPENDIENTEMENTE ENTRE ATOMOS DE HIDROGENO Y GRUPOS ALQUILO C SUB,1-3}, A CONDICION DE QUE R SUP,1} Y R SUP,2} Y/O R SUP,4} Y R SUP,5} PUEDEN FORMAR JUNTOS UN GRUPO METILENO O ETILENO, Y N, M Y L SON 0 O 1, EN LA PREPARACION DE UN MEDICAMENTO PARA MEJORAR LA FUNCION HEPATICA, PARA REDUCIR EL NIVEL DE COLESTEROL O PARA REDUCIR EL NIVEL DE GRASA NEUTRA. LOS COMPUESTOS ADECUADOS INCLUYEN SESAMINA, SESAMINOL, EPISESAMINA, EPISESAMINOL, SESAMOLIN, 2 -(3,4 METOXI .0]OCTANO Y 2 HIDROXIFENOXI)
ES97112930T 1989-07-21 1990-07-20 Uso terapeutico de compuestos de dioxabiciclo(3.3.0.)octano. Expired - Lifetime ES2195058T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1187497A JP3001589B2 (ja) 1989-07-21 1989-07-21 リグナン類含有飲食物
JP8750090 1990-04-03

Publications (1)

Publication Number Publication Date
ES2195058T3 true ES2195058T3 (es) 2003-12-01

Family

ID=26428763

Family Applications (3)

Application Number Title Priority Date Filing Date
ES97112930T Expired - Lifetime ES2195058T3 (es) 1989-07-21 1990-07-20 Uso terapeutico de compuestos de dioxabiciclo(3.3.0.)octano.
ES90307978T Expired - Lifetime ES2161680T3 (es) 1989-07-21 1990-07-20 Mejorador de la funcion del higado.
ES97112931T Expired - Lifetime ES2235205T3 (es) 1989-07-21 1990-07-20 Capsula que contiene compuestos de dioxabiciclo (3.3.0)octano.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES90307978T Expired - Lifetime ES2161680T3 (es) 1989-07-21 1990-07-20 Mejorador de la funcion del higado.
ES97112931T Expired - Lifetime ES2235205T3 (es) 1989-07-21 1990-07-20 Capsula que contiene compuestos de dioxabiciclo (3.3.0)octano.

Country Status (8)

Country Link
US (1) US5180588A (es)
EP (3) EP0409654B1 (es)
AT (3) ATE208195T1 (es)
CA (2) CA2172855C (es)
DE (3) DE69034181T2 (es)
DK (3) DK0818196T3 (es)
ES (3) ES2195058T3 (es)
SG (1) SG42967A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3183664B2 (ja) * 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
US20020031563A1 (en) * 1992-09-30 2002-03-14 Hodge Thomas W. Method of inhibiting tumor necrosis factor
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
ES2202454T3 (es) * 1995-07-04 2004-04-01 Suntory Limited Uso de un agente equilibrante para acidos grasos insaturados omega-3 y omega-6.
FR2738828B1 (fr) * 1995-09-20 1997-10-17 Commissariat Energie Atomique Utilisation de cyclodextrines naturelles et de leurs derives pour la solubilisation d'agents anti-agregants plaquettaires de la famille des ginkgolides
AU7068896A (en) * 1995-11-09 1997-05-15 Corunum Corporation Protein composition derived from sesame seed and use thereof
US5811313A (en) * 1997-06-17 1998-09-22 King Pharmaceuticals, Inc. Identification test for highly refined sesame oil
CA2461661A1 (en) * 2001-10-19 2003-05-01 Maxim Pharmaceuticals, Inc. Use of histamine to treat liver disease
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
FI114917B (fi) * 2002-08-29 2005-01-31 Hormos Nutraceutical Oy Ltd Lignaanikomplekseja
SG158183A1 (en) * 2004-12-28 2010-01-29 Suntory Holdings Ltd Sesamin/episesamin compositions
JP5096138B2 (ja) * 2005-03-31 2012-12-12 サントリーホールディングス株式会社 リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物
US7943663B2 (en) 2005-09-30 2011-05-17 Suntory Holdings Limited Process and an apparatus for producing episesamin-rich compositions
JP5069416B2 (ja) * 2006-03-15 2012-11-07 サントリーホールディングス株式会社 吸湿性の改善された飲食品用組成物
MY163134A (en) * 2006-03-15 2017-08-15 Suntory Holdings Ltd Composition containing riboflavin and sesamin-class compounds
SG10201601998PA (en) 2006-03-31 2016-04-28 Suntory Holdings Ltd Jp Compositions containing lignan-class compounds
JP5591533B2 (ja) * 2007-03-15 2014-09-17 サントリーホールディングス株式会社 抗疲労剤
JP5450075B2 (ja) * 2007-09-19 2014-03-26 サントリーホールディングス株式会社 セサミン類とビタミンｂ１類とを配合した組成物
KR101528380B1 (ko) * 2007-09-19 2015-06-11 산토리 홀딩스 가부시키가이샤 세사민류와 아라키돈산류를 함유하는 조성물
JP6156795B2 (ja) * 2013-07-05 2017-07-05 公立大学法人大阪市立大学 脂肪細胞分化の抑制用、脂肪細胞の脂肪蓄積量低減用および／または脂肪細胞のアディポネクチン分泌促進用組成物
CN104804012B (zh) * 2015-04-24 2017-06-30 沈阳药科大学 一种具有抗耐药菌活性的化合物止泻木脂素a及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427694A (en) * 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
HU202855B (en) * 1986-06-13 1991-04-29 Tsumura & Co Process for producing new biphenyl derivatives and pharmaceutical compositions containing them as active components
JPH01135892A (ja) * 1987-11-20 1989-05-29 Kuki Sangyo Kk 抗酸化性物質の製造方法
US4868207A (en) * 1988-07-28 1989-09-19 Taisho Pharmaceutical Co., Ltd. Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
JPH02255616A (ja) * 1989-03-27 1990-10-16 Rooman Kogyo:Kk 肝臓疾患用剤

Also Published As

Publication number Publication date
DE69034181T2 (de) 2006-01-26
DE69034084D1 (de) 2003-07-10
CA2021714A1 (en) 1991-01-22
DE69033848T2 (de) 2002-04-04
EP0826369A1 (en) 1998-03-04
DE69034084T2 (de) 2003-12-04
US5180588A (en) 1993-01-19
EP0818196A1 (en) 1998-01-14
CA2021714C (en) 1996-07-23
ATE208195T1 (de) 2001-11-15
DK0818196T3 (da) 2005-05-02
DE69033848D1 (de) 2001-12-13
CA2172855C (en) 2000-02-15
EP0826369B1 (en) 2003-06-04
SG42967A1 (en) 1997-10-17
DK0409654T3 (da) 2001-12-27
CA2172855A1 (en) 1991-01-22
EP0818196B1 (en) 2004-12-29
EP0409654A2 (en) 1991-01-23
DE69034181D1 (de) 2005-02-03
DK0826369T3 (da) 2003-09-29
EP0409654B1 (en) 2001-11-07
ES2161680T3 (es) 2001-12-16
ATE241978T1 (de) 2003-06-15
EP0409654A3 (en) 1992-05-27
ES2235205T3 (es) 2005-07-01
ATE285765T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
ES2195058T3 (es) Uso terapeutico de compuestos de dioxabiciclo(3.3.0.)octano.
ES2072387T3 (es) Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.
ES2000297A6 (es) Procedimiento para preparar oxaespiro-2-aminociclohecilacetamidas con actividad analgesica
IL77452A0 (en) Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
EP0340754A3 (en) Monopersulfates of amino-(poly) percarboxylic acids
EP0488513A3 (en) Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
WO1999030722A8 (en) Pharmaceutical compositions for mucolysis and treatment of inflammation
EP0681788A3 (en) Dioxabicyclo[3.3.0] octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
IL77151A0 (en) Triazole derivatives,their use as fungicides and pharmaceutical compositions containing them
IL78273A0 (en) (4.2.0)bicyclooctane derivatives,their preparation and pharmaceutical compositions containing them
EP0204148A3 (en) [1,4]Benzodioxin and [1,4]benzoxazine derivatives
JPS5436255A (en) Novel sesquiterpene analogue, its preparation, and pharmatheutical containing the same
AU5140490A (en) Use of mixed micelles
EP0304842A3 (en) Isoprenoid derivatives and anti-ulcer agents containing the same
JPS5323997A (en) Imidazoquinazoline derivatives and their preparation
IE900218L (en) Benzopyran derivatives
SE8600411D0 (sv) Isokinolinderivat, deras framstellning och anvendning
JPS5430151A (en) 3-hydroxy-2-cyclohexene-1-one derivatives and their preparation
JPS5325554A (en) 2-omega,omega-bis(alkyulthio)-or omega,omega(alkylenedithio)-alkyl-5-methylfuran and their preparation
JPS53102985A (en) Cyclodextrin derivative and its produdtion
JPS56103178A (en) Pyrimidinoaminomethylenemalonic cyclic ester and its preparation
JPS53137970A (en) Sterylglucoside acetal derivatives
SU1513867A1 (ru) 2,2'-азобис{2-циано-5-[6-или(4-метил-3)(2,3-эпоксипропоксикарбамино)гексил - или (фенил)аминокарбокси]пентаны} в качестве промежуточных продуктов для получения эпоксидных олигомеров
JPS53124241A (en) Methylenomycin a derivatives and their preparation
ES8602825A1 (es) Un procedimiento para preparar un compuesto fosforoditioico